What is RMD's Value Score?

ResMed Inc. Common Stock (RMD) has a StockPik Value Score of 89 out of 100 — a high score, indicating strong value characteristics across multiple metrics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is RMD's Piotroski F-Score?

ResMed Inc. Common Stock (RMD) has a Piotroski F-Score of 6 out of 9 — a moderate score. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

Is RMD trading below its Graham Number?

RMD is currently trading above its Graham Number. The stock price of $200.29 exceeds the Graham Number of $103.52, meaning it does not meet Graham's criterion for a margin of safety at the current price. The Graham Number is calculated as √(22.5 × EPS × Book Value Per Share) and represents Benjamin Graham's ceiling price for a defensive investor.

What is RMD's Graham Number?

RMD's Graham Number is $103.52, calculated using the Benjamin Graham formula √(22.5 × EPS × Book Value per Share). The Graham Number is an estimate of intrinsic value — the maximum price a defensive investor should pay. At the current price of $200.29, RMD is trading 93% above its Graham Number.

What is RMD's Piotroski F-Score?

RMD's Piotroski F-Score is 6 out of 9, indicating moderate financial health. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is RMD (ResMed Inc. Common Stock) undervalued?

RMD scores 89/100 on StockPik's Value Score, placing it in undervalued territory. The stock trades 93% above its Graham Number of $103.52.

What is RMD's P/E ratio?

RMD's trailing P/E ratio is 19.2x — a reasonable earnings multiple. The Healthcare sector average P/E is 25.2x. Compare against other Healthcare stocks in the StockPik screener.

Does ResMed Inc. Common Stock (RMD) pay a dividend?

Yes, RMD currently pays a dividend yield of 1.2%. View the full dividend and value analysis on StockPik.

What sector is ResMed Inc. Common Stock (RMD) in?

ResMed Inc. Common Stock (RMD) is in the Healthcare sector, specifically in the Surgical & Medical Instruments & Apparatus industry. Compare it against other Healthcare stocks by Value Score, P/E ratio, and Piotroski F-Score on StockPik.

Back to Screener

ResMed Inc. Common Stock (RMD)

NYSE Large Cap

Healthcare › Surgical & Medical Instruments & Apparatus

$200.29

Market Cap: $28.9B

Data as of Mar 31, 2026 (TTM)

Price History

Feb 9, 2026 — Aug 14, 2026

Investment Snapshot

Trading 93% above Graham Number — above intrinsic value estimate
Piotroski F-Score 6/9 — moderate financial health
Strong ROE of 22.9% with 27.5% net margin
Revenue growing at 10% annually

ResMed Inc. Common Stock (RMD) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $28.9 billion . Key value metrics: P/E ratio 19.2, P/B ratio 4.39, Piotroski F-Score 6 out of 9 (moderate financial health) .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

19.20

P/B Ratio

4.39

EPS

$10.43

Div. Yield

1.2%

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Current vs 5-Year Average

Based on 5 years of SEC filings

Net Margin

—

↑ +2.1pp avg —

Gross Margin

—

↑ +2.1pp avg —

Operating Margin

—

↑ +2.1pp avg —

Return on Equity

—

↑ +2.1pp avg —

Debt / Equity

—

↑ +2.1pp avg —

See How Margins & ROE Have Trended — Try PRO

Revenue & Net Income

Profit Margins

Track Gross, Operating & Net Margins — Try PRO

EPS & Free Cash Flow Per Share

See EPS & Free Cash Flow Trends — Try PRO

Financial Statements

Metric	FY22	FY23	FY24
Revenue	$X.XB	$X.XB	$X.XB
Gross Profit	$X.XB	$X.XB	$X.XB
Operating Income	$X.XB	$X.XB	$X.XB
Net Income	$X.XB	$X.XB	$X.XB
EBITDA	$X.XB	$X.XB	$X.XB
Total Assets	$X.XB	$X.XB	$X.XB
Total Liabilities	$X.XB	$X.XB	$X.XB

Unlock 5 Years of Financials — Start Free Trial

Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

ResMed Inc. Common Stock — Fundamental Analysis Summary

ResMed Inc. Common Stock (RMD) is currently trading 93% above its Graham Number of $103.52, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 19.2x.

On financial health, RMD shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 22.9% (sector average: -20.1%), and minimal leverage with a debt-to-equity ratio of 0.10.

StockPik's composite Value Score for RMD is 89/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

RMD reports a high gross margin of 61.2% (sector average: 37.4%) and a strong operating margin of 34.0%.

RMD shows revenue growing at 10% year-over-year, with earnings growing at 9%.

RMD pays a modest dividend yield of 1.2%.

Top Value Stocks in Healthcare

Symbol	Name	Price	P/E	Score
CGEN	Compugen Ltd. - Ordinary Shares	$2.28	6.1	100
ABEO	Abeona Therapeutics Inc. - Common Stock	$5.99	5.2	100
GMAB	Genmab A/S - American Depositary Shares	$33.45	2.2	100
EMBC	Embecta Corp. - Common Stock	$3.29	1.7	100
CRMD	CorMedix Inc. - Common Stock	$8.75	3.5	100

Browse all Healthcare value stocks →

How is the Value Score calculated?

Read our full methodology →

How is the Graham Number calculated?

Benjamin Graham's intrinsic value formula, worked examples, and how to use it →

RMCO — Royalty Management Holding Corporation - Class A Common Stock

Suncrete, Inc. - Class A Common Stock — RMIX